.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster

PS2-NO-A41

Utility of DNA-methylation profiling and Integrated Molecular-Morphologic Meningioma classification as a prognostic biomarker in CNS WHO grade 2 meningiomas – a retrospective feasibility study in a patient cohort with resected meningiomas in New Zealand

Presented in

Neurooncology self study Meningioma and other non-glial tumors

Poster topics

Neurooncology self study

Meningioma and other non-glial tumors

Authors

Fouzia Ziad (Hamilton, NZ), Tania Slatter (Dunedin, NZ), Greg Jones (Dunedin, NZ), Adriana Saraiva (Dunedin, NZ), Ziad Thotathil (Hamilton, NZ), Monish Maharaj (Hamilton, NZ), Basharat Bhat (Dunedin, NZ), Peter Gan (Hamilton, NZ), Noelyn Hung (Dunedin, NZ), Michael Jameson (Hamilton, NZ)